KLOW peptide references and study notes
To me, the vessel papers supply the opening question. The full list below also includes the skin, bowel, material and safety research that surrounds the blend.
Vascular experiments
Hsieh and colleagues examined BPC-157 and vasomotor tone in 2020. Jo and colleagues studied VEGF expression after full-length thymosin beta-4. Lane and colleagues traced angiogenic copper-binding fragments released from SPARC. These are different approaches to the blood-supply question; none tested KLOW.
Repair and human observations
The rat Achilles-tendon experiment and rat wound-healing experiment supply repair outcomes. The GHK reviews cover skin regeneration and topical human findings and gene-expression data. The BPC-157 safety pilot followed two adults, while the Sports Medicine review assesses the wider safety gap.
The hair-follicle review and BPC-157 neurotransmitter review extend the component discussion. I treat a proposed mechanism in a review as a reason for a test, rather than a measured benefit of KLOW.
Intestinal cells and biomaterials
Dalmasso and colleagues studied KPV uptake and intestinal inflammation. Separate papers examine a KPV-loaded mucoadhesive hydrogel and a hydrogel that stabilises KPV for controlled release. The skin-adaptive growth-factor dressing study is broader biomaterial context; it does not demonstrate a KLOW effect.
The WADA prohibited list addresses sports rules. Its role in the list below is regulatory, rather than evidence of a repair outcome.
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. ↗
- Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. ↗
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. ↗
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. ↗
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. ↗
- Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. ↗
- Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. ↗
- Xiao X, et al. Multiple potential roles of thymosin β4 in the growth and development of hair follicles. J Cell Mol Med. 2021. ↗
- Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. Journal of Cell Biology. 1994;125(4):929-943. ↗
- Hsieh MJ, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep. 2020;10:17078. ↗
- Jo JO, et al. Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner. Biochim Biophys Acta. 2010. ↗
- Zhou F, et al. In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect. Biomater Sci. 2022;10(7):1644-1655. ↗
- Zhao Y, et al. Skin-adaptive film dressing with smart-release of growth factors accelerated diabetic wound healing. Int J Biol Macromol. 2022;222(Pt A):1738-1748. ↗
- Zhang Q, et al. Self-Cross-Linked Hydrogel of Cysteamine-Grafted gamma-Polyglutamic Acid Stabilized Tripeptide KPV for Treating Inflammatory Bowel Disease. ACS Biomater Sci Eng. 2021;7(10):4938-4949. ↗
- World Anti-Doping Agency (WADA). Prohibited List 2025. S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics. ↗
- Sikiric P, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals (Basel). 2024;17(4):461. ↗